Publication:
Prevalence and factors linked to renal involvement in prediabetes patients across Europe in the ePREDICE trial

dc.contributor.authorMás-Fontao, Sebastián
dc.contributor.authorCivantos, Esther
dc.contributor.authorBoukichou-Abdelkader, Nisa
dc.contributor.authorMoreno, Juan A
dc.contributor.authorTuomilehto, Jaakko
dc.contributor.authorGabriel-Sanchez, Rafael
dc.contributor.authorEgido, Jesús
dc.contributor.funderUnión Europea. Comisión Europea. 7 Programa Marco
dc.contributor.funderInstituto de Salud Carlos III
dc.contributor.funderUnión Europea. Fondo Europeo de Desarrollo Regional (FEDER/ERDF)
dc.contributor.funderCentro de Investigación Biomédica en Red - CIBERDEM (Diabetes y Enfermedades Metabólicas asociadas)
dc.contributor.funderInstituto de Investigación Sanitaria de la Fundación Jiménez Díaz
dc.contributor.funderMerck KGaA
dc.contributor.funderBoehringer Ingelheim Fonds
dc.date.accessioned2025-03-05T15:36:44Z
dc.date.available2025-03-05T15:36:44Z
dc.date.issued2024-12-05
dc.description.abstractThis sub-analysis of the ePREDICE trial, investigated the prevalence and determinants of renal complications, specifically glomerular hyperfiltration, albuminuria, and reduced kidney function, in individuals with prediabetes (PD). The cohort consisted of 967 participants from diverse backgrounds across seven countries. The kidney function was evaluated using the MDRD-4 equation, and the influence of various clinical and demographic factors on renal involvement was assessed by multivariable regression models. Additionally, insulinogenic and disposition indices were examined. Overall, the prevalence of renal abnormalities in this PD cohort was 9.2% (n = 89). Key findings included the detection of hyperfiltration in 20 (2%) individuals, albuminuria in 45 (4.7%), and CKD stage G3a in 29 (3%). Hyperfiltration was inversely correlated with age and height, while albuminuria showed a significant direct association with the disposition index (DI). Age and waist circumference were significantly and directly associated with estimated glomerular filtration rate (eGFR). The ePREDICE study highlights critical factors that affect renal involvement in PD individuals, revealing complex interactions among various parameters. These findings further emphasize the necessity for the search of early kidney abnormalities in people with PD especially in those in older age groups and with a large waist circumference.
dc.description.peerreviewed
dc.description.sponsorshipAll the funding or sources of support received during this specific study: - European Commission, FP7 EC GA No. 279074 - Merck-Serono, Germany - Boeringher Ingelheim, Germany (IIS Program. Grant number 1218.166) - Instituto de Salud Carlos III, Spain PI11/01653 The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The IIS-FJD diabetes research group was funded by Instituto de Salud Carlos III/FEDER (PI20/00487, PI23/00119), Spanish Biomedical Research Centre in diabetes and metabolic diseases (CIBERDEM) and Spanish Society of Nephrology (SEN).
dc.format.number1
dc.format.page30336
dc.format.volume14
dc.identifier.citationMas-Fontao S, Civantos E, Boukichou N, Moreno JA, Tuomilehto J, Gabriel R, Egido J. Prevalence and factors linked to renal involvement in prediabetes patients across Europe in the ePREDICE trial. Sci Rep. 2024 Dec 5;14(1):30336.
dc.identifier.doi10.1038/s41598-024-79842-w
dc.identifier.e-issn2045-2322
dc.identifier.journalScientific reports
dc.identifier.pubmedID39638835
dc.identifier.urihttps://hdl.handle.net/20.500.12105/26396
dc.language.isoeng
dc.publisherNature Publishing Group
dc.relation.projectIDinfo:eu-repo/grantAgreement/EC/FP7/279074/EU
dc.relation.projectIDinfo:eu-repo/grantAgreement/MICINN//PI11%2F01653/ES/Optimizando la conservación y recuperación de la célula ß-pancreática en individuos con tolerancia alterada a la glucosa y diabetes tipo2 de reciente comienzo: Proyecto ß-PREDICE/
dc.relation.projectIDinfo:eu-repo/grantAgreement/ISCIII/Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020 (ISCIII)/PI20%2F00487/ES/INFLAMACION COMO DIANA TERAPEUTICA EN LAS COMPLICACIONES DE LA DIABETES TIPO 2/
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/PI23/00119
dc.relation.publisherversionhttps://doi.org/10.1038/s41598-024-79842-w
dc.repisalud.centroISCIII::Escuela Nacional de Sanidad (ENS)
dc.repisalud.institucionISCIII
dc.repisalud.instituteIIS::IIS-FJD - Instituto de Investigación Sanitaria Fundación Jiménez Díaz (Madrid)
dc.repisalud.instituteIIS::IMIBIC - Instituto Maimónides de Investigación Biomédica de Córdoba (Andalucía)
dc.rights.accessRightsopen access
dc.rights.licenseAttribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subjectAlbuminuria
dc.subjectBiomarkers
dc.subjectChronic kidney disease (CKD)
dc.subjectEstimated glomerular filtration rate (eGFR)
dc.subjectPrediabetes
dc.subject.meshAdult
dc.subject.meshAged
dc.subject.meshAlbuminuria
dc.subject.meshEurope
dc.subject.meshFemale
dc.subject.meshGlomerular Filtration Rate
dc.subject.meshHumans
dc.subject.meshKidney
dc.subject.meshMale
dc.subject.meshMiddle Aged
dc.subject.meshPrediabetic State
dc.subject.meshPrevalence
dc.subject.meshRenal Insufficiency, Chronic
dc.subject.meshRisk Factors
dc.titlePrevalence and factors linked to renal involvement in prediabetes patients across Europe in the ePREDICE trial
dc.typeresearch article
dc.type.hasVersionVoR
dspace.entity.typePublication
relation.isAuthorOfPublication2a4245cf-fbe4-49f6-b2fa-444c7a813c0c
relation.isAuthorOfPublication.latestForDiscovery2a4245cf-fbe4-49f6-b2fa-444c7a813c0c
relation.isFunderOfPublication453a1d63-c349-4a0e-b0f2-f4edba065c75
relation.isFunderOfPublication7d739953-4b68-4675-b5bb-387a9ab74b66
relation.isFunderOfPublicationefa64f05-b985-4984-8f1e-5fc4ef21f502
relation.isFunderOfPublicationc24bb53d-2e03-4d69-b37f-9db9a67aba25
relation.isFunderOfPublicationafe74350-80f5-4552-8d64-c787ec7bf6cb
relation.isFunderOfPublicationddc9939e-77d1-4d96-a189-37851ec0975b
relation.isFunderOfPublication6e3d618b-53a8-47e9-ab5f-637382022607
relation.isFunderOfPublication.latestForDiscovery453a1d63-c349-4a0e-b0f2-f4edba065c75
relation.isPublisherOfPublication301fb00e-338e-4f8c-beaa-f9d8f4fefcc0
relation.isPublisherOfPublication.latestForDiscovery301fb00e-338e-4f8c-beaa-f9d8f4fefcc0

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
PrevalenceFactorsLinkedRenal_2024.pdf
Size:
2.35 MB
Format:
Adobe Portable Document Format